# OnCo record thxid-braf (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/thxid-braf/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "thxid-braf" ;
  schema:name "THxID BRAF Kit"@en ;
  schema:alternateName "THXID BRAF Kit"@en, "bioMérieux THxID BRAF"@en, "THxID BRAF" ;
  schema:description "bioMérieux's BRAF test for melanoma, approved with dabrafenib and trametinib in 2013; the FDA's device database records its approval as withdrawn in 2024."@en ;
  schema:url <https://onco.cc/drugs/thxid-braf/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P120014>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "withdrawn" ;
  onco:tag "test" ;
  onco:modality "PCR companion diagnostic test (BRAF V600E and V600K, melanoma tissue)" ;
  onco:approval "US 2013: Companion diagnostic for dabrafenib (V600E) and trametinib (V600E or V600K) in melanoma", "US 2018: Companion diagnostic for encorafenib with binimetinib" ;
  onco:related <https://onco.cc/drugs/cobas-4800-braf-v600/>, <https://onco.cc/biomarkers/braf-v600e/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/braf/> ;
  onco:drugs <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/>, <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/binimetinib/> ;
  onco:companies <https://onco.cc/companies/biomerieux/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/companion-diagnostic-term/> .